This study enrolls patients with newly diagnosed differentiated thyroid cancer (papillary thyroid cancer or follicular thyroid cancer) that has spread to the lungs and has a genetic mutation called and RET fusion.
Pediatric Cancer Survivorship Outcomes is a division-wide, outcomes-based clinical research program invested in creating a core community of CHOP and Penn researchers committed to improving the health of childhood cancer survivors across their lifespan.
The Bauer Lab focuses on improving our understanding of the molecular landscape of pediatric thyroid cancer in an effort to optimize the diagnostic accuracy of fine needle aspiration, identify markers that predict invasive behavior and prognosis, and identify targets for improved treatment options.
This study enrolls patients with newly diagnosed differentiated thyroid cancer (papillary thyroid cancer or follicular thyroid cancer) that has spread to the lungs and has a genetic mutation called and NTRK fusion.
The Child and Adolescent Thyroid Consortium (CATC) Biorepository is a collaborative research program dedicated to studying thyroid cancers and other thyroid-related conditions.
Dr. Franco researches the molecular basis of the differences between pediatric and adult onset thyroid cancer. She aims to understand how the tumor microenvironment impacts disease progression and response to therapy.
